Retinol Palmitate
- done All payments are SSL encrypted
- done Full Refund if you haven't received your order
- done International shipping to the USA, UK and Europe
Clinical Pharmacology
Means for moistening, lubrication and protection of the cornea.
Evenly distributing and holding on the cornea for a long time, VitA-POS improves the condition of the tear film and thus reliably protects the cornea from drying out.
Vitamin A contained in the product is a natural component of the tear film and gives the product a delicate oily consistency, which ensures its complete mixing with natural tear and good tolerance of the product.
The use of VitA-POS contributes to the rapid disappearance of the subjective symptoms of burning, dryness and discomfort in the eyes.
Indications
Improves the condition of the tear film and protects the eye surface, helping to eliminate discomfort when feeling "dry", foreign body sensation, burning in the eyes, including those that occur under the influence of:
- Climatic factors such as air conditioning in the car, in the plane; wind, cold, intense solar radiation, ecologically unhealthy air or cigarette smoke
- Intense visual load, for example, during long-term work with a computer, a camera, with excessive spending time in front of the TV, the need to control vehicles at night, during prolonged wearing of contact lenses
Composition
1 g of lubricating ophthalmic contains:
Active ingredients
Retinol palmitate 250 IU.
Vaseline white, liquid paraffin, light liquid paraffin, lanolin.
No customer reviews for the moment.
Dosage and Administration
A strip of 1 cm long is placed in the conjunctival sac 1-3 times / day. The frequency of use of the tool is set individually, as needed, and as recommended by an ophthalmologist. The use of VitA-POS before bedtime is recommended.
The duration of treatment is not limited.
Contraindications
Hypersensitivity to the components of the drug.
Drug interactions
VitA-POS should not be used simultaneously with other ophthalmological agents. In cases where joint use cannot be avoided, the use of VitA-POS is recommended 30 minutes after using another drug.
Special instructions
VitA-POS should not be used when wearing contact lenses. It is recommended to use the product after removing the lenses.
The use of VitA-POS can lead to a slight deterioration in visual acuity, therefore it is recommended to use it before going to bed at night.
When using VitA-POS, the tip of the tube should be avoided with the surface of the eye and skin.
Influence on ability to drive motor transport and control mechanisms
Immediately after the use of VitA-POS, a short-term impairment of visual acuity may occur, leading to a slowdown of mental and physical reactions. Therefore, it is not recommended to use VitA-POS immediately before working with the mechanisms and driving vehicles.
- Inhibition by tunicamycin of mucin synthesis, not morphological changes, in epidermis during retinol-induced mucous metaplasia of chick embryonic cultured skin
- Vitamin A and cancer prevention II: Comparison of the effects of retinol and β-carotene
- ASSESSMENT OF SERUM LEVELS OF α-1-MICROGLOBULIN, β-2-MICROGLOBULIN, AND RETINOL BINDING PROTEIN IN THE FETAL BLOOD. A METHOD FOR PRENATAL EVALUATION OF RENAL FUNCTION
- Lobe of origin and histologic type of lung cancer associated with asbestos exposure in the carotene and retinol efficacy trial (CARET)
- Coexpression of the mRNAs encoding retinol dehydrogenase isozymes and cellular retinol-binding protein
- MMH cells: An in vitro model for the study of retinol-binding protein secretion regulated by retinol
- Plasma tocopherol, retinol, and carotenoid concentrations in free-ranging Humboldt penguins (Spheniscus humboldti) in Chile
- Circulating levels of α-tocopherol and retinol in free-ranging African elephants (Loxodonta africana)
- Determination of retinol, α-tocopherol, α- and β-carotene by direct extraction of human serum using high performance liquid chromatography
- Content of dolichol and retinol in isolated rat non-parenchymal liver cells
- The interactions between cellular retinol-binding protein (CRBP-I) and retinal: A vibrational spectroscopic study
- Impaired retinol utilization in Adh4 alcohol dehydrogenase mutant mice
- Presence of cellular retinol and retinoic acid-binding proteins in epidermoid carcinoma of the oral cavity and oropharynx
- Cellular retinol-binding proteins in head and neck tumors and their adjacent tissues
- The relationship of dietary intake and serum levels of retinol and beta-carotene with breast cancer. Results of a case-control study
- Dietary antioxidant vitamins, retinol, and breast cancer incidence in a cohort of Swedish women
- Metabolic conversion of retinol to retinoic acid mediates the biological responsiveness of human mammary epithelial cells to retinol
- Retinol conversion to retinoic acid is impaired in breast cancer cell lines relative to normal cells
- The effects of nonadecafluoro-n-decanoic acid on serum retinol and hepatic retinyl palmitate hydrolase activity in male sprague-dawley rats
- Downregulation of hepatic stellate cell activation by retinol and palmitate mediated by adipose differentiation-related protein (ADRP)
- Regeneration of whole limbs in toad tadpoles treated with retinol palmitate after the wound-healing stage
- Emulsion and Vesicle Formation of Retinol and Retinyl Palmitate with Egg Yolk Phosphatidylcholine
- Determination of nine carotenoids, retinol, retinyl palmitate and α-tocopherol in control human serum using two internal standards
- Simultaneous determination of retinol, α-tocopherol and retinyl palmitate in plasma of premature newborns by reversed-phase high-performance liquid chromatography